2022 annual financial data
Niagen Bioscience 2022 Net margin
Direct answer
Net margin was -22.96%.
Operating income was -18,628,000 USD and net income was -16,540,000 USD.
Operating cash flow was -15,098,000 USD.
Get free Niagen Bioscience email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 72,050,000 USD
- Operating income
- -18,628,000 USD
- Net income
- -16,540,000 USD
- Operating cash flow
- -15,098,000 USD